Vaishali Pharma Ltd Share Price & Stock Analysis

Vaishali Pharma Ltd (NSE: VAISHALI) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹91 Cr, it ranks #3,322 by market cap among the 6,197 Indian listed companies on FinBizNet, and #69 of 86 in Medicinal Chemicals and Botanical Products. At ₹7.11 (as of 16 Nov 2026), the share price is 28.0% below its 52-week high of ₹9.87 and 49.7% above its 52-week low of ₹4.75. The share price is down 28.2% over one year and down 16.5% over three months.

Key Metrics

Current Price₹7.11
Market Cap₹91 Cr
NSE SymbolVAISHALI
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio22.1
Return on Equity1.52%
Return on Assets1.88%
52-Week Range₹4.75 – ₹9.87
1-Year Price Change-28.2%
3-Month Price Change-16.5%
Beta (1Y)0.31
HeadquartersMumbai, Maharashtra
Websitewww.vaishalipharma.com

Latest Quarterly Results — Q2 FY27

Revenue₹30 Cr
Net Profit₹2 Cr
Net Margin6.8%
EPS (Basic)₹0.16
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Vaishali Pharma Ltd Quarterly Revenue and Profit Trend

Vaishali Pharma Ltd reported revenue of ₹30 Cr in Q2 FY27, down 9.8% from ₹33 Cr in Q2 FY26 and up 31.8% from ₹23 Cr in Q1 FY27. It posted a net profit of ₹2 Cr for the quarter, against a net profit of ₹1 Cr in Q2 FY26 (up 74.6%). Across the 5 quarters from Q2 FY26 to Q2 FY27, quarterly revenue ranged from ₹23 Cr (Q1 FY27) to ₹33 Cr (Q2 FY26). The company was profitable in each of these 5 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹30 Cr₹2 Cr6.8%
Q1 FY27₹23 Cr₹1 Cr6.5%
Q4 FY26₹27 Cr₹0 Cr1.4%
Q3 FY26₹25 Cr₹1 Cr5.3%
Q2 FY26₹33 Cr₹1 Cr3.5%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 31.61% of Vaishali Pharma Ltd's shares as of Sept 2026, unchanged from Dec 2025. Delivery averaged 72.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Vaishali Pharma Ltd

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti–malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-viral, anti-epileptic, anti-asthmatic, enzymes, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helminitic. The company also provides formulations, including antibiotics, antibacterial, anti-platelet, laxative, anti-ulcer, enzymes, anti-asthmatic, anti-malarial, anti-cold, anti-allergic, anti-viral, anti-psychotic, anti-fungal, vitamins, topical steroids, corticosteroids, anti-inflammatory, analgesic, anti-pyretic, anti-diabetic, cardiac, and other products. In addition, it offers disposable surgical and casting tape products; herbal products; veterinary products; nutraceutica

Products and Services

1. Sale of Pharmaceutical Products-This segment offers pharmaceutical formulations, active pharmaceutical ingredients, surgical products, veterinary supplements, and herbal and nutraceutical products.

Business Segments

1. Sale of Pharmaceutical Products-100%

Vaishali Pharma Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Vaishali Pharma Ltd₹91 Cr22.11.52%₹30 Cr-28.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Vaishali Pharma Ltd?

Vaishali Pharma Ltd is trading at ₹7.11, with a market capitalisation of ₹91 Cr.

Which sector does Vaishali Pharma Ltd belong to?

Vaishali Pharma Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Vaishali Pharma Ltd?

Vaishali Pharma Ltd has a P/E of 22.1 and a return on equity of 1.52%.

What is the stock symbol of Vaishali Pharma Ltd?

Vaishali Pharma Ltd is listed on the NSE under the symbol VAISHALI.

How has Vaishali Pharma Ltd's share price moved over the past year?

Vaishali Pharma Ltd's share price is down 28.2% over one year and down 16.5% over three months. Its 52-week range is ₹4.75 to ₹9.87.

What were Vaishali Pharma Ltd's latest quarterly results?

In Q2 FY27, Vaishali Pharma Ltd reported revenue of ₹30 Cr and net profit of ₹2 Cr, with basic EPS of ₹0.16 (consolidated, parsed from the company's exchange filing).

How have Vaishali Pharma Ltd's revenue and profit changed over the past year?

Vaishali Pharma Ltd reported revenue of ₹30 Cr in Q2 FY27, down 9.8% from ₹33 Cr in Q2 FY26 and up 31.8% from ₹23 Cr in Q1 FY27.

What is the promoter holding in Vaishali Pharma Ltd?

Promoters held 31.61% of Vaishali Pharma Ltd's shares as of Sept 2026, unchanged from Dec 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.